Drug Shortage Report for DOCETAXEL INJECTION USP

Last updated on 2024-04-10 History
Report ID 223128
Drug Identification Number 02361957
Brand name DOCETAXEL INJECTION USP
Common or Proper name DOCETAXEL INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DOCETAXEL
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 16mL vial
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-09
Estimated end date 2024-04-29
Actual end date
Shortage status Actual shortage
Updated date 2024-04-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-04-10 French Compare
v4 2024-04-10 English Compare
v3 2024-04-02 English Compare
v2 2024-03-22 French Compare
v1 2024-03-22 English Compare

Showing 1 to 5 of 5